This announcement is a separate document:
国投证券股份有限公司关于深圳微芯生物科技股份有限公司向不特定对象发行可转换公司债券受托管理事务报告（2023年度）
CSI Securities Co., Ltd.'s entrusted management report on Shenzhen Chipscreen Biosciences Co., Ltd.'s issuance of convertible corporate bonds to unspecified objects (2023). Bonds.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.